Disclosure Of Effect Of Changes In Foreign Exchange Rates [Text Block]

ABIVAX - Filing #5984181

Concept 2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
As at
2024-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
Disclosure of effect of changes in foreign exchange rates [text block]
Reserve of exchange differences on translation
75,000 EUR
112,000 EUR
EUR
Disclosure of information when currency is not exchangeable into another currency [text block]
Disclosure of information when foreign operation’s functional currency is not exchangeable into presentation currency [text block]
Disclosure of summarised financial information about foreign operation [text block]
Disclosure of summarised financial information about foreign operation [abstract]
Disclosure of summarised financial information about foreign operation [line items]
Non-current assets
34 558 EUR
41 090 EUR
39 363 EUR
Current assets
170 671 EUR
285 972 EUR
36 181 EUR
Non-current liabilities
70 645 EUR
40 356 EUR
16 891 EUR
Current liabilities
93 999 EUR
90 695 EUR
51 464 EUR
Profit (loss)
176 242 EUR
EUR
176 242 EUR
EUR
EUR
EUR
176 242 EUR
147 740 EUR
147 740 EUR
147 740 EUR
EUR
EUR
EUR
EUR
EUR
60 740 EUR
EUR
60 740 EUR
EUR
EUR
Other comprehensive income
EUR
31,000 EUR
EUR
EUR
187,000 EUR
219,000 EUR
225,000 EUR
EUR
225,000 EUR
112,000 EUR
EUR
112,000 EUR
EUR
EUR
235,000 EUR
235,000 EUR
EUR
235,000 EUR
EUR
EUR
Comprehensive income
176 242 EUR
31,000 EUR
EUR
EUR
187,000 EUR
176 461 EUR
147 516 EUR
147 740 EUR
112,000 EUR
EUR
112,000 EUR
EUR
EUR
60 506 EUR
235,000 EUR
60 740 EUR
EUR
EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.